Stein Mart, Inc. to Present at Credit Suisse Small & Mid Cap Conference
Get Alerts SMRT Hot Sheet
Join SI Premium – FREE
JACKSONVILLE, Fla., Aug. 23, 2016 (GLOBE NEWSWIRE) -- Stein Mart, Inc. (NASDAQ: SMRT) announced today that Dawn Robertson, the Company's Chief Executive Officer and Greg Kleffner, the Company's Chief Financial Officer, will be presenting at the 7th Annual Credit Suisse Small & Mid Cap Conference being held at the Waldorf Astoria Hotel in New York City on Wednesday, September 14, 2016. Given the conference format, a web cast is not available for this presentation.
Stein Mart management will also host one-on-one meetings with interested investors during the conference. For more information on the conference or to schedule a one-on-one meeting, please contact a Credit Suisse representative or the conference coordinator at: [email protected].
A copy of the Stein Mart’s latest investor presentation is available in the Investor Relations section of the Company’s website at http://ir.steinmart.com.
About Stein MartStein Mart, Inc. (NASDAQ: SMRT) is a national retailer offering designer and name-brand fashion, accessories and home decor at everyday discount prices. Stein Mart provides real value that customers will love every day both in stores and online. Stein Mart currently operates 283 stores across 31 states and has plans to expand over the next year. Stein Mart is adding new modern brands to its stores this year to offer discriminating shoppers even more of the fashion and savings they want. For more information, please visit www.steinmart.com.
SMRT-G
For more information: Linda L. Tasseff Director, Investor Relations (904) 858-2639 [email protected]Source: Stein Mart, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ZTO Files Annual Report on Form 20-F for Fiscal Year 2023
- Dimensional Fund Advisors Ltd. : Form 8.3 - MONDI PLC - Ordinary Shares
- Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!